Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Redd

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Haematologica|May 28, 2026
A phase I/II study of twice-weekly ixazomib plus pomalidomide and dexamethasone in relapsed and refractory multiple myelomaOmar Nadeem, Robert A Redd, Peter M Barth, et al.
Developmental Cell|December 13, 2023
HOPX-associated molecular programs control cardiomyocyte cell states underpinning cardiac structure and functionClayton E Friedman, Seth W Cheetham, Sumedha Negi, et al.
Blood Advances|January 24, 2022
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort studyJ Erika Haydu, Jenny S Maron, Robert A Redd, et al.
Nature Communications|April 8, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM studyOmar Nadeem, Michelle P Aranha, Robert A Redd, et al.
Blood Cancer Discovery|December 5, 2022
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic VulnerabilitiesElisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.
Cancer Cell|November 15, 2022
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myelomaRomanos Sklavenitis-Pistofidis, Michelle P Aranha, Robert A Redd, et al.
Circulation|July 15, 2021
Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion InjuryMeredith A Redd, Sarah E Scheuer, Natalie J Saez, et al.
Socio-Ecological Practice Research|November 21, 2022
Advancing the scholarship and practice of stakeholder engagement in working landscapes: a co-produced research agendaWeston M Eaton, Morey Burnham, Tahnee Robertson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 9, 2023
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheepLouise E See Hoe, Gianluigi Li Bassi, Karin Wildi, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Haematologica|May 28, 2026
A phase I/II study of twice-weekly ixazomib plus pomalidomide and dexamethasone in relapsed and refractory multiple myelomaOmar Nadeem, Robert A Redd, Peter M Barth, et al.
Developmental Cell|December 13, 2023
HOPX-associated molecular programs control cardiomyocyte cell states underpinning cardiac structure and functionClayton E Friedman, Seth W Cheetham, Sumedha Negi, et al.
Blood Advances|January 24, 2022
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort studyJ Erika Haydu, Jenny S Maron, Robert A Redd, et al.
Nature Communications|April 8, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM studyOmar Nadeem, Michelle P Aranha, Robert A Redd, et al.
Blood Cancer Discovery|December 5, 2022
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic VulnerabilitiesElisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, et al.
JAMA|August 8, 2023
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical TrialTomas G Neilan, Thiago Quinaglia, Takeshi Onoue, et al.
Cancer Cell|November 15, 2022
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myelomaRomanos Sklavenitis-Pistofidis, Michelle P Aranha, Robert A Redd, et al.
Circulation|July 15, 2021
Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion InjuryMeredith A Redd, Sarah E Scheuer, Natalie J Saez, et al.
Socio-Ecological Practice Research|November 21, 2022
Advancing the scholarship and practice of stakeholder engagement in working landscapes: a co-produced research agendaWeston M Eaton, Morey Burnham, Tahnee Robertson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 9, 2023
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheepLouise E See Hoe, Gianluigi Li Bassi, Karin Wildi, et al.
Pageof 8